Amphastar Pharmaceuticals Price to Sales Ratio 2012-2024 | AMPH
Historical PS ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current P/S ratio for Amphastar Pharmaceuticals as of November 22, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Amphastar Pharmaceuticals P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-11-21 |
44.55 |
|
3.23 |
| 2024-09-30 |
48.53 |
$13.79 |
3.52 |
| 2024-06-30 |
40.00 |
$13.45 |
2.97 |
| 2024-03-31 |
43.91 |
$12.69 |
3.46 |
| 2023-12-31 |
61.85 |
$12.15 |
5.09 |
| 2023-09-30 |
45.99 |
$11.36 |
4.05 |
| 2023-06-30 |
57.47 |
$10.29 |
5.59 |
| 2023-03-31 |
37.50 |
$9.87 |
3.80 |
| 2022-12-31 |
28.02 |
$9.49 |
2.95 |
| 2022-09-30 |
28.10 |
$9.34 |
3.01 |
| 2022-06-30 |
34.79 |
$9.31 |
3.74 |
| 2022-03-31 |
35.90 |
$9.04 |
3.97 |
| 2021-12-31 |
23.29 |
$8.80 |
2.65 |
| 2021-09-30 |
19.01 |
$8.33 |
2.28 |
| 2021-06-30 |
20.16 |
$7.76 |
2.60 |
| 2021-03-31 |
18.32 |
$7.54 |
2.43 |
| 2020-12-31 |
20.11 |
$7.22 |
2.79 |
| 2020-09-30 |
18.75 |
$6.94 |
2.70 |
| 2020-06-30 |
22.46 |
$6.86 |
3.27 |
| 2020-03-31 |
14.84 |
$6.61 |
2.24 |
| 2019-12-31 |
19.29 |
$6.44 |
3.00 |
| 2019-09-30 |
19.83 |
$6.70 |
2.96 |
| 2019-06-30 |
21.11 |
$6.66 |
3.17 |
| 2019-03-31 |
20.43 |
$6.61 |
3.09 |
| 2018-12-31 |
19.90 |
$6.28 |
3.17 |
| 2018-09-30 |
19.24 |
$5.59 |
3.44 |
| 2018-06-30 |
15.26 |
$5.23 |
2.92 |
| 2018-03-31 |
18.75 |
$5.07 |
3.70 |
| 2017-12-31 |
19.24 |
$4.99 |
3.85 |
| 2017-09-30 |
17.87 |
$5.08 |
3.52 |
| 2017-06-30 |
17.86 |
$5.22 |
3.42 |
| 2017-03-31 |
14.50 |
$5.34 |
2.72 |
| 2016-12-31 |
18.42 |
$5.43 |
3.40 |
| 2016-09-30 |
18.97 |
$5.80 |
3.27 |
| 2016-06-30 |
16.12 |
$5.87 |
2.75 |
| 2016-03-31 |
12.00 |
$5.59 |
2.15 |
| 2015-12-31 |
14.23 |
$5.60 |
2.54 |
| 2015-09-30 |
11.69 |
$5.22 |
2.24 |
| 2015-06-30 |
17.58 |
$5.15 |
3.42 |
| 2015-03-31 |
14.96 |
$5.18 |
2.89 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.186B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
